A study involving nearly 600 women from clinics in California, Colorado, Illinois, Kansas, and Minnesota challenges the necessity of the FDA's Patient Agreement Form for mifepristone, arguing it provides no additional useful information and slows access to abortion pills. However, the study reveals significant gaps in women's knowledge about the correct use and risks of the abortion pill, underscoring the importance of these forms to ensure women are fully informed and protected.
Read →Tag
Abortion Industry
Content substantially addressing abortion industry.
A 30-year-old woman suffered serious complications, including excessive bleeding and unconsciousness, during a late-term abortion at the Trust Women clinic in Wichita, Kansas, which has a history of compliance issues and previous closures. The incident highlights ongoing safety concerns at Kansas abortion facilities amid a significant increase in abortions and clinics in the state since 2019.
Read →Showing 2 of 2